- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitisKittichai Promrat
Division of Gastroenterology and Hepatology, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
Hepatology 51:121-9. 2010..36 versus -0.41, P < 0.001), lobular inflammation (-0.82 versus -0.24, P = 0.03), ballooning injury (-1.27 versus -0.53, P = 0.03) and NAS (-3.45 versus -1.18, P < 0.001)...
- Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophyKenneth Shieh
Division of Gastroenterology and Hepatology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, 110 Lockwood Street, Suite 116, Providence, Rhode Island 02903, USA
Muscle Nerve 41:197-201. 2010..It is strongly associated with markers of insulin resistance and features of the metabolic syndrome. These findings support the role of peripheral insulin resistance in the pathogenesis of NAFLD...
- Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levelsKittichai Promrat
Division of Gastroenterology and Hepatology Liver Research Center, Rhode Island Hospital Department of Pathology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA
Hepatol Res 41:754-62. 2011..005). Conclusion: NASH is associated with increased insulin resistance and altered ceramide gene expression in liver. Weight loss-mediated reversal of NASH is associated with reduced pro-ceramide gene expression in liver...